Shkreli's Price-Hike Brag: '$1bn Here We Come'

Excerpts from more than 300,000 documents, including emails, from Turing Pharmaceuticals Inc. and Valeant Pharmaceuticals International Inc. painted a picture that's anything but pretty about how those firms went about buying older drugs and jacking up their prices – with the now-former head of one of those companies, Martin Shkreli, declaring "$1bn here we come."